Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision MedicineFrançoise Derouane, François P. Duhoux|Cancers|2022Cited by 89
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancersFrançoise Derouane, Cyril Corbet|Breast Cancer Research|2024Cited by 23